Promoted Content Promoted Content


Find Clinical Drug Development Pipelines & Deals | PipelineProspector


All Data

Filters Filter refresh
News Type filter
    Company filter
      Product Type filter
        Deal Size filter
          Upfront Payment filter

            Product Type Full Screen

            Companies Full Screen

            Virtual Booth Upgrade this company profile, update & customize all content// Ask PharmaCompass, click HERE

            Contact the Supplier

            Lead Product(s): Risperidone

            Therapeutic Area: Psychiatry/Psychology Product Name: TV46000-CNS-30072

            Highest Development Status: Phase III Product Type: Small molecule

            Partner/Sponsor/Collaborator: MedinCell

            Deal Size: Not Applicable Upfront Cash: Not Applicable

            Deal Type: Not Applicable January 07, 2021


            Data from the study showed that patients who received risperidone had a statistically significant delay in time to relapse as compared to placebo, thus meeting the primary endpoint.